Unichem Laboratories has received final approval from the USFDA to market generic Irbesartan tablets, used in treating hypertension, in the American market. The tablets are therapeutically equivalent to Sanofi- -aventis’s Avapro tablets, which are indicated for the treatment of hypertension. It is also used for the treatment of diabetic nephropathy. The product would be commercialised from Unichem’s Ghaziabad plant. Active Pharmaceutical Ingredient (API) for the product would also made in-house at Pithampur plant.
Company Profile : Unichem Laboratories Ltd
Leave a Reply